Clinical Efficacy and Adverse Event of Remdesivir Treatment in Seven COVID-19 Cases with Respiratory Failure

  • KIMURA Takuya
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • BABA Rie
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • OKABE Taro
    Department of General medicine, Saiseikai Utsunomiya Hospital
  • FUJII Ryo
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • MINAGAWA Yusuke
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • FUJITA Kensuke
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • KADOYA Takashi
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • KAMO Tetsuro
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • TAKAI Chihiro
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • YAMADA Sou
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • KOINUMA Toshiki
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • HAGIWARA Yoshihiro
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • MISUMI Kayo
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • KOBAYASHI Takaomi
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • YAMANAKA Takahiro
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital
  • TAKAHASHI Hidenori
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • KOMURA Masayoshi
    Department of General medicine, Saiseikai Utsunomiya Hospital
  • ARAI Daisuke
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • NAGAO Genta
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • KONISHI Shunichiro
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • KAMIMOTO Shigenobu
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • NAKACHI Ichiro
    Department of Respiratory medicine, Saiseikai Utsunomiya Hospital
  • OGURA Takayuki
    Department of Emergency & Intensive care, Saiseikai Utsunomiya Hospital

Bibliographic Information

Other Title
  • レムデシビルで治療された呼吸不全合併COVID-19 7 例において観察された臨床的効果と有害事象について

Search this article

Abstract

<p>A preliminary report from a global study showed that remdesivir, a nucleoside analog pro-drug that was originally developed as a therapeutic drug against Ebola virus, may exert clinical efficacy in cases of COVID-19, by shortening the time to recovery. We had the opportunity to use this new drug in the treatment of 7 COVID-19 patients with respiratory failure.</p>

Journal

  • Kansenshogaku Zasshi

    Kansenshogaku Zasshi 95 (2), 147-152, 2021-03-20

    The Japanese Association for Infectious Diseases

References(8)*help

See more

Details 詳細情報について

Report a problem

Back to top